Dr. Marco Favetta | Radiation Physics Awards | Best Researcher Award

Dr. Marco Favetta, ASP Trapani, Italy

Marco Favetta is an accomplished medical physicist currently serving as the Head of the Medical Physics and Trapani Radiotherapy Departmental Unit at A.S.P. Trapani since 2024. he has built a robust career in medical physics, with prior roles as Dirigent Physicist at the University Hospital Consortium Company Polyclinic of Bari and ASST-Lodi. Marco obtained his Diploma of Specialization in Medical Physics from the University of Catania with top honors, and he holds a PhD in Physics focused on medical applications. He has extensive teaching experience, having lectured on medical physics and applied physics at the University of Catania. Marco is also recognized for his contributions to research, including collaboration with ELI Beamlines in Prague, where he led projects in innovative radiotherapy technologies. His professional expertise extends to HR and economic management within healthcare, showcasing his managerial skills in resolving complex issues and fostering collaboration among multidisciplinary teams. Marco is dedicated to advancing medical physics through research, education, and innovation, making significant contributions to the field and mentoring future professionals.

Professional Profile:

ORCID

Summary of Suitability for the Best Researcher Award

Based on the impressive qualifications and contributions of Marco Favetta, I believe he is exceptionally suitable for the Best Researcher Award. His extensive research background, particularly in the field of Medical Physics and laser-driven technologies, demonstrates a strong commitment to advancing knowledge and innovation in photonics and radiation therapy.

Education 🎓

Specialization in Medical Physics
University of Catania
Date: 15 July 2014
Grade: 70/70
Thesis: “Special Techniques of Radiotherapy: from planning to treatment verifications”
PhD in Physics, Medical Physics
University of Salento
Date: 2 May 2007 – 30 April 2010
Thesis: “MR image analysis for the early diagnosis of Alzheimer’s dementia: identification of a template base for the hippocampus area”
Degree in Physics
University of Catania
Date: 20 December 2006
Grade: 110/110
Thesis: “Detection of neutrinos of very high energy: study of underwater acoustic background noise”

Work Experience 💼

Head of Medical Physics and Trapani Radiotherapy Departmental Unit
A.S.P. Trapani
Date: 2024 – Present
Dirigent Physicist, Medical Physics
University Hospital Consortium Company Polyclinic of Bari
Date: 2017 – 2024
Dirigent Physicist, Medical Physics (on leave)
A.S.P. Siracusa
Date: 2020 – 2021
Dirigent Physicist, Medical Physics
ASST-Lodi
Date: 2015 – 2017
Senior Post Doc
IMM-CNR, Catania, Italy
Date: 2014 – 2015
Scientific Associate
CNR – IMM
Date: 2013 – 2015
Junior Post Doc
INFN, National Laboratories of the South, Catania, Italy
Date: 2011 – 2012
Graduate School of Medical Physics
University of Catania, Italy
Date: 2010 – 2014
Scientific Associate
INFN
Date: 2005 – 2014

Achievements 🏆

Notable managerial skills demonstrated at the Polyclinic of Bari, with recognition from the head of the U.O.S.D. of Health Physics.
Collaboration with the ELI Beamlines research center in Prague, coordinating experiments and overseeing a diverse team.
Developed international collaborations and networks in oncology, dosimetry, and X-ray imaging.
Participated in the Megatalenti project, presenting a business idea and creating a corresponding business plan.

Awards and Honors 🥇

Recognized for dedication and passion for research and innovation.
Solid reference point for colleagues, demonstrating leadership and the ability to inspire.

Publication Top Notes:

Characterization of kHz Repetition Rate Laser-Driven Electron Beams by an Inhomogeneous Field Dipole Magnet Spectrometer

BIOESOnet: A Tool for the Generation of Personalized Human Metabolic Pathways from 23andMe Exome Data

Silicon nitride surfaces as active substrate for electrical DNA biosensors

Development of Si-based electrical biosensors: Simulations and first experimental results

ELIMED: a new hadron therapy concept based on laser driven ion beams

Dr. Kei Ito ,Tokyo Metropolitan Komagome Hospital, Japan

Dr. Kei Ito, born on June 1, 1985, in Japan, is a distinguished specialist in Radiation Oncology affiliated with the Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital. His career is marked by a dedication to advancing cancer treatment through innovative radiotherapeutic techniques.Dr. Ito’s educational journey began at Juntendo University School of Medicine, where he earned his M.D. degree in 2011. He continued his residency and fellowship training at Tokyo Metropolitan Komagome Hospital and Juntendo University, specializing in Radiation Oncology. His expertise spans various areas, including stereotactic body radiotherapy, management of bone metastases, and treatment of cervical cancer and head and neck cancers.As a recognized leader in his field, Dr. Ito has received numerous accolades for his contributions to oncology research and education. Notably, he was awarded the Best of ASTRO Abstract in 2020, the Excellent Education Lecture Award at the JASTRO annual meetings in 2021 and 2023, and the Excellent Paper Award from the Japan Radiological Society in 2023, among others.Dr. Ito’s commitment to improving patient outcomes through cutting-edge treatments and his proactive involvement in academic research make him a pivotal figure in the field of Radiation Oncology in Japan and beyond.

Education/Career History:

Apr 2005 – Mar 2011: Juntendo Univ. School of Medicine

Apr 2011 – Mar 2013: Junior Resident, Juntendo Univ. Urayasu Hospital

Apr 2013 – Mar 2016: Senior Resident, Dept. of Radiation Oncology, Tokyo Metropolitan Komagome Hospital

Apr 2014 – Mar 2018: Graduate School of Juntendo Univ., Dept. of Radiation Oncology

Apr 2016 – Mar 2019: Clinical Fellow, Dept. of Radiation Oncology, Tokyo Metropolitan Komagome Hospital

Apr 2019 – Present: Medical Staff, Dept. of Radiation Oncology, Tokyo Metropolitan Komagome Hospital

Publication top Notes:

Phase II Clinical Trial of Second Course of Stereotactic Body Radiotherapy for Spinal Metastases

Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy

Evaluation of the MVCT-based radiomic features as prognostic factor in patients with head and neck squamous cell carcinoma

Who should receive single-fraction palliative radiotherapy for gastric cancer bleeding?: An exploratory analysis of a multicenter prospective observational study (JROSG 17-3)

Pain Response Rates After Conventional Radiation Therapy for Bone Metastases Assessed Using International Consensus Pain Response Endpoints: A Systematic Review and Meta-Analysis of Initial Radiation Therapy and Reirradiation